Your browser doesn't support javascript.
loading
Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study.
Kraaijpoel, Noémie; Di Nisio, Marcello; Mulder, Frits I; van Es, Nick; Beyer-Westendorf, Jan; Carrier, Marc; Garcia, David; Grosso, Michael; Kakkar, Ajay K; Mercuri, Michele F; Middeldorp, Saskia; Hernandez, Cristhiam Rojas; Santamaria, Amparo; Schwocho, Lee; Segers, Annelise; Verhamme, Peter; Wang, Tzu-Fei; Weitz, Jeffrey I; Zhang, George; Zwicker, Jeffrey I; Büller, Harry R; Raskob, Gary E.
Afiliação
  • Kraaijpoel N; Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Di Nisio M; Department of Medicine and Ageing Sciences, University G. D'Annunzio, Chieti, Italy.
  • Mulder FI; Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • van Es N; Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Beyer-Westendorf J; Department of Medicine I, University Hospital Dresden, Dresden, Germany.
  • Carrier M; Department of Medicine, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Garcia D; Department of Hematology, University of Washington, Seattle, Washington, United States.
  • Grosso M; Daiichi Sankyo Pharma Development, Basking Ridge, New Jersey, United States.
  • Kakkar AK; Thrombosis Research Institute, University College London, London, United Kingdom.
  • Mercuri MF; Daiichi Sankyo Pharma Development, Basking Ridge, New Jersey, United States.
  • Middeldorp S; Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Hernandez CR; MD Anderson Cancer Center, University of Texas, Houston, Texas, United States.
  • Santamaria A; Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain.
  • Schwocho L; Daiichi Sankyo Pharma Development, Basking Ridge, New Jersey, United States.
  • Segers A; ITREAS, Academic Research Organization, Amsterdam, The Netherlands.
  • Verhamme P; University Hospitals Leuven, University of Leuven, Leuven, Belgium.
  • Wang TF; The Ohio State University Wexner Medical Center, Columbus, Ohio, United States.
  • Weitz JI; Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Ontario, Canada.
  • Zhang G; Daiichi Sankyo Pharma Development, Basking Ridge, New Jersey, United States.
  • Zwicker JI; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States.
  • Büller HR; Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Raskob GE; University of Oklahoma Health Sciences Center, College of Public Health, University of Oklahoma, Oklahoma City, Oklahoma, United States.
Thromb Haemost ; 118(8): 1439-1449, 2018 Aug.
Article em En | MEDLINE | ID: mdl-30060256
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Piridinas / Tiazóis / Dalteparina / Tromboembolia Venosa / Inibidores do Fator Xa / Hemorragia / Anticoagulantes / Neoplasias Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Piridinas / Tiazóis / Dalteparina / Tromboembolia Venosa / Inibidores do Fator Xa / Hemorragia / Anticoagulantes / Neoplasias Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article